| 000 | 01638 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515021738.0 | ||
| 264 | 0 | _c20060803 | |
| 008 | 200608s 0 0 eng d | ||
| 022 | _a0028-2685 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStyczynski, J | |
| 245 | 0 | 0 |
_aResistance to glucocorticoids in childhood acute lymphoblastic leukemia: impact of relationship between ex vivo sensitivity and in vivo concentration on risk factor analysis. _h[electronic resource] |
| 260 |
_bNeoplasma _c2006 |
||
| 300 |
_a168-73 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B _xbiosynthesis |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacokinetics |
| 650 | 0 | 4 |
_aApoptosis _xphysiology |
| 650 | 0 | 4 |
_aAsparaginase _xpharmacokinetics |
| 650 | 0 | 4 |
_aBody Fluids _xchemistry |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xphysiology |
| 650 | 0 | 4 | _aFactor Analysis, Statistical |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucocorticoids _xpharmacokinetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aLethal Dose 50 |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aModels, Theoretical |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aVincristine _xpharmacokinetics |
| 700 | 1 | _aKoltan, A | |
| 700 | 1 | _aWysocki, M | |
| 773 | 0 |
_tNeoplasma _gvol. 53 _gno. 2 _gp. 168-73 |
|
| 999 |
_c16182210 _d16182210 |
||